Not available
Quote | Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)
Last: | $1.815 |
---|---|
Change Percent: | 1.4% |
Open: | $1.79 |
Close: | $1.79 |
High: | $1.85 |
Low: | $1.762 |
Volume: | 37,943 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)
2024-03-19 21:02:11 ET Corvus Pharmaceuticals, Inc. (CRVS) Q4 2023 Earnings Conference Call March 19, 2024 04:30 PM ET Company Participants Zack Kubow - Real Chemistry Leiv Lea - CFO Richard Miller - CEO Jeff Arcara - CBO Conference Call Participants ...
2024-03-19 16:04:18 ET More on Corvus Pharmaceuticals Seeking Alpha’s Quant Rating on Corvus Pharmaceuticals Historical earnings data for Corvus Pharmaceuticals Financial information for Corvus Pharmaceuticals Read the full article on Seeking Alpha ...
Message Board Posts | Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)
Subject | By | Source | When |
---|---|---|---|
Price now | masterofdisaster | investorshub | 05/16/2023 8:15:50 AM |
$CRVS short squeeze | BooDog | investorshub | 05/16/2023 3:50:49 AM |
$CRVS Good read | masterofdisaster | investorshub | 05/15/2023 2:21:46 PM |
$CRVS Price now last trade up | gene_genome | investorshub | 05/14/2023 11:20:05 PM |
$CRVS MomentumIts now up | masterofdisaster | investorshub | 05/14/2023 3:57:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for atopic dermatitis Orphan drug designation and new interim data from Phase 1/1b clinical trial further demonstrate soquelitinib’s potentia...
BURLINGAME, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, ...
BURLINGAME, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on March 19, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update a...